281 Inflammation in OA is closely related to the activation of macrophages
Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026
:46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria
In primate models, Epithalon has been reported to normalize or modulate melatonin secretion patterns in age-related or experimentally altered conditions
(Defines the roles of major selenoproteins, including glutathione peroxidases and thioredoxin reductases.) Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R